Drug Trial Radar · NCT00146835
Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine
Last checked: Nov 19, 2026Latest source record: Jan 13, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
120,794
Actual
Start
Apr 2003
Primary completion
Jun 2006
Study completion Jun 2006
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- Collaborators
- Kaiser Permanente; University of California, Los Angeles
- First posted
- Sep 7, 2005
Design
- Study type
- Observational
- Who can join
- All sexes, from 6 weeks, up to 9 months
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Pre-licensure studies of GSK Biologicals' PEDIARIX vaccine have shown it to be generally safe and unlikely to result in vaccine-associated serious adverse events. This post-licensure study is designed to evaluate relatively uncommon/rare outcomes in a large population cohort.
Conditions
- Hepatitis B
- Poliomyelitis
- Diphtheria
- Tetanus
- Acellular Pertussis
Interventions
PediarixBiological
1 or more injections
Licensed DTPa containing vaccineBiological
1 or more injections
Prevnar®: (Wyeth)Biological
Concomitant vaccination
Primary outcomes
What the sponsor says the trial is designed to measure.
- All seizures following the primary doses of PEDIARIX in Cohort A and DTaP vaccine in Cohort BTime frame: During the 8-day period following the primary dose
- Medically-attended fever following the first dose of PEDIARIX in Cohort A and DTaP vaccine in Cohort BTime frame: Within 4 days following the first dose
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.